Abbott Presents Data Showing its Glucose Monitor Helps People With Diabetes

At the 13th Advanced Technologies & Treatments for Diabetes meeting, Abbott Laboratories (NYSE: ABT) is presenting a series of studies showing that its glucose monitor FreeStyle Libre system helped people with diabetes across the globe improved their glucose levels. The system uses a sensor that's worn on the back of the patient's upper arm, eliminating the need for routine finger pricks.

In a study of patients with Type 1 or Type 2 diabetes in Germany, after using the FreeStyle Libre system for 12 months, patients were able to reduce their HbA1c level, a measure of long-term glucose levels. Type 1 patients with starting values greater than 7.5% lowered their HbA1c by 1.4%, while Type 2 patients reduced the measurement by 1.2%.

An analysis by Abbott of patients in Sweden's National Diabetes Register showed patients using the system for three months to nine months had a 0.44% reduction in HbA1c for people with Type 1 diabetes and 0.67% for people with Type 2 diabetes.

Continue reading

Source Fool.com